Skip to main content
Sign In
 

Research

An Impressive Track Record


 

School of Medicine has a record of success and expertise in innovation, discovery and commercialization of therapies, drugs and medical devices. Our faculty members translate basic sciences into medical breakthroughs that help people around the world. 

Anschutz Medical Campus researchers, the bulk of whom work for the School of Medicine, attracted $395.2 million in grants in the 2012-13 fiscal year - more than any of the other CU campuses, including Boulder.

Firsts:  

  • Researchers at the School of Medicine have designed mice that do not get fat when on a high-fat diet – a breakthrough that could address obesity in humans because humans have the same gene.
  • A CU Cancer Center study published in 2013 shows that bitter melon juice restricts pancreatic cancer cells from metabolizing glucose, thus cutting their energy source. 
  • School of Medicine professor Iñigo San Millán, PhD, is applying his research by working with the Colorado Buffaloes football team to improve player performance.
  • School of Medicine research, published in 2013,  found that dietary supplements of choline – a nutrient in liver, fish, nuts and eggs – during pregnancy lowers physiological risk factors of schizophrenia in infants. The first human liver transplant was performed by a surgical team from the CU School of Medicine.
  • School of Medicine researchers led the identification of child abuse with the publication in 1962 of their paper The Battered-Child Syndrome.
  • The “Visible Human Project,” a detailed, digital-image, 3-D representation of the human body, was led by the School of Medicine.

Research Newsroom

 

Curing Dengue

CU researchers may help scientists develop treatments or vaccines for Dengue fever, West Nile virus, Yellow fever, Japanese encephalitis and other disease-causing flaviviruses.

Q-A - Alzheimers Disease

Huntington Potter, PhD, answers your questions about Alzheimer's Disease.

Zombie Cancer Cells

A cancer cell killed by chemotherapy doesn't necessarily stay dead, CU researchers have learned.

Solving the Sniffles Mystery

CU researchers are closing in on the cause of a common of ailment – the runny nose.

Medical Research Incubator Rises

Bioscience 2 on the Fitzsimons Life Science District will house CU's bioengineering graduate program and startup medical companies.

Strokes Likely to Follow Shingles

Stroke risk is high following a shingles episode, but patients who take antiviral medication have a reduced risk.

Severity of Autism Link

CU researchers have found a segment of DNA that might be linked to the severity of autism.

MS and Marijuana

Marijuana in pill or spray form reduces MS symptoms, and many patients are using it, despite the lack of thorough research.

The Secret to Alligator Ears

A CU researcher says alligators' mysteriously good hearing is the result of air-filled channels connecting the middle ears - a trait similar to that of birds.

Allergy Reactions to Joint Implants

Pain following a joint replacement may be caused by an allergic reaction to materials used in the operation.

Grant for Childhood Stroke Research

Anschutz researchers earned a $3 million grant to study causes and treatment of childhood strokes, which cause lifelong problems.

A Cure for Hep C

A new drug tested at University of Colorado Hospital can cure most patients with Hepatitis C within 12 weeks, researchers say.

Fast-track Drugs Helping Patients

Leukemia patients in clinical trials at Anschutz are taking advantage of life-saving drugs made available by new federal legislation.

Melanoma Therapy Working

A two-drug therapy that blocks separate melanoma growth pathways is helping patients at CU Cancer Center.

Decades-Old Research Trial Keeps Going

A study founded in 1993 with 30,000 participants is helping CU's Barbara Davis Center answer the question: Why do some people get Type 1 diabetes?